Tuesday, July 12, 2016 10:20:37 PM
Read the abstract:
http://www.aaai.org/Papers/Symposia/Spring/2007/SS-07-07/SS07-07-012.pdf
Spencer did his focus group about 10 years before and when he went into the home trials they interacted with the elderly and he knew in advance that the CareBot would fit through the doors.
It's a paper about a preliminary study, not an in home alpha trial of a functioning system. It seems to use predecessors of AVA, which is still a developmental platform. IRobot's current medical telepresence platform is for hospitals and it's so expensive they can't sell it, they can only lease it to selected customers, apparently for extended alpha testing. It is not a marketable product.
GeckoSystems has the only eldercare robot that has been thoroughly Alpha tested and is ready for final development and Beta testing. It could be on the Japanese market by 2015, the first mobile service robot to qualify for 90% coverage under Japanese nursing care insurance.
GeckoSystems also has the only wheelchair with a marketable AI robotic navigation system. With adequate funding or the right partner or licensee it will be on the market in a matter of months.
FEATURED DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • Nov 7, 2024 2:16 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM